Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Germantown, MD
SEC filing record 1 source field available
Fiscal year end
31 December
Barinthus Biotherapeutics plc. has filed 254 SEC EDGAR filings since 23 Dec 2020

SEC filing history

Showing 1-25 of 254 matching filings.

Per page
25
Current page
1
ARS File 001-40367

ARS

Filing date
10 Jun 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-40367

DEF 14A

Filing date
10 Jun 2026
Reporting date
02 Jul 2026
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
01 May 2026
Reporting date
01 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFM14A File 001-40367

DEFM14A

Filing date
30 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D File 005-93002

SCHEDULE 13D filing

Filing date
13 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-40367

425

Filing date
23 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-40367

425

Filing date
30 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-40367

425

Filing date
30 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .